Delayed sensitization to heat by inhibitors of polyamine-biosynthetic enzymes.

Abstract:

:Exposure of Chinese hamster ovary cells to the enzyme inhibitors methylglyoxal bis(guanylhydrazone and alpha-difluoromethylornithine (DFMO) results in increased sensitivity to hyperthermia. While methylglyoxal bis(guanylhydrazone) demonstrates pronounced cytotoxicity at moderate extracellular concentrations, DFMO is tolerated well by this cell line at concentrations of up to 10 mM, as assayed by clonogenic survival after treatments at 37 degrees. An 8-hr preincubation at 37 degrees with either drug elicits increasing sensitivity to 43 degrees hyperthermia treatments with time after removal of the drug. In contrast to results obtained by heating in the presence of the drugs during the 8-hr exposure, DFMO acts as the more effective sensitizing agent for this delayed effect on progeny of DFMO-treated populations. This phenomenon seems to result from depletion of intracellular putrescine, because the effect can be at least partially recovered by providing the cells with an exogenous source of this diamine. The potential for in vivo heat sensitization by the non-toxic agent DFMO has yet to be investigated but may have intriguing clinical possibilities.

journal_name

Cancer Res

journal_title

Cancer research

authors

Fuller DJ,Gerner EW

subject

Has Abstract

pub_date

1982-12-01 00:00:00

pages

5046-9

issue

12

eissn

0008-5472

issn

1538-7445

journal_volume

42

pub_type

杂志文章
  • Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin.

    abstract::We established a cisplatin-resistant human ovarian cancer cell line (HAC2/0.1) from the parent cell line (HAC2/P) by continuous exposure of HAC2/P to 0.1 microgram of cisplatin/ml. Drug sensitivity determined by colony assay revealed that HAC2/0.1 was 2.4 times as resistant to cisplatin as the parental cell line. HAC2...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Niimi S,Nakagawa K,Sugimoto Y,Nishio K,Fujiwara Y,Yokoyama S,Terashima Y,Saijo N

    更新日期:1992-01-15 00:00:00

  • Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.

    abstract::Estrogen receptor (ER)-positive human breast cancer cells are hormonally regulated and are inhibited by retinoids, whereas most ER-negative breast cancer cells are not. Here, we compared retinoid-induced transcriptional activation and growth inhibition in the ER-negative breast cancer cell line MDA-MB-231, stably tran...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosenauer A,Nervi C,Davison K,Lamph WW,Mader S,Miller WH Jr

    更新日期:1998-11-15 00:00:00

  • Role of activated protein C in facilitating basement membrane invasion by tumor cells.

    abstract::The present study was undertaken to investigate the role of plasminogen activator inhibitor type 1 (PAI-1) and activated protein C (APC) in the regulation of tumor cell invasion. PAI-1 was purified in active form from conditioned medium of human umbilical vein endothelial cells under denaturing conditions (4 M guanidi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kobayashi H,Moniwa N,Gotoh J,Sugimura M,Terao T

    更新日期:1994-01-01 00:00:00

  • Has the well gone dry? The First Cain Memorial Award Lecture.

    abstract::Contrary to a recent suggestion, new and useful drugs for the treatment of human cancer continue to be developed although clinical trials today are more difficult and the chances for success are diminished. In the past, research at Southern Research Institute led to the development of two new classes of clinically use...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Montgomery JA

    更新日期:1982-10-01 00:00:00

  • Prolactin and estrogen binding in transplantable hormone-dependent and autonomous rat mammary carcinoma.

    abstract::A hormone-dependent subline of the transplantable rat mammary tumor MTW9 contains binding sites for both prolactin and estrogen. Prolactin binding is saturable (K-d similar to 2 times 10-9 M), hormone specific, and destroyed by proteases. By contrast, an autonomous subline derived from the same parent tumor has lost m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Costlow ME,Buschow RA,Richert NJ,McGuire WL

    更新日期:1975-04-01 00:00:00

  • Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action.

    abstract::Endometrial carcinoma is associated with antecedent simple and complex hyperplasia, and the endometrium is a target tissue for the action of cytokines and growth factors. Transforming growth factor (TGF)-beta s are potent cellular growth and differentiation regulatory factors. Therefore, we investigated the potential ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gold LI,Saxena B,Mittal KR,Marmor M,Goswami S,Nactigal L,Korc M,Demopoulos RI

    更新日期:1994-05-01 00:00:00

  • Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.

    abstract::Using computerized pharmacy records from 1969 to 1973 for a cohort of 143,574 members of the Kaiser Permanente Medical Care Program, we have been testing associations of 215 drugs or drug groups with subsequent incidence of cancer at 56 sites. This paper presents findings with follow-up through 1984. There were 227 st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Selby JV,Friedman GD,Fireman BH

    更新日期:1989-10-15 00:00:00

  • Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.

    abstract::Checkpoint inhibitors are relatively inefficacious in head and neck cancers, despite an abundance of genetic alterations and a T-cell-inflamed phenotype. One significant barrier to efficacy may be the recruitment of myeloid-derived suppressor cells (MDSC) into the tumor microenvironment. Here we demonstrate functional...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-2534

    authors: Davis RJ,Moore EC,Clavijo PE,Friedman J,Cash H,Chen Z,Silvin C,Van Waes C,Allen C

    更新日期:2017-05-15 00:00:00

  • Distal nephron renal tumors: microsatellite allelotype.

    abstract::Tumors of varying malignant potential arise from the complex epithelial lining of the nephron. Although the molecular characteristics of renal clear cell carcinomas, which arise from the proximal tubule, have been studied, little is known about tumors that develop from other parts of the renal tubular system. To eluci...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Polascik TJ,Cairns P,Epstein JI,Fuzesi L,Ro JY,Marshall FF,Sidransky D,Schoenberg M

    更新日期:1996-04-15 00:00:00

  • Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats.

    abstract::The effect of dietary intake of different levels of Menhaden fish oil on azoxymethane-induced carcinogenesis was examined in male F344 rats fed the semipurified diets. Starting at 5 weeks of age, groups of animals were fed the 5% corn oil (low corn oil) diet. At 7 weeks of age, all animals except the vehicle-treated c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reddy BS,Maruyama H

    更新日期:1986-07-01 00:00:00

  • Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

    abstract::Estrogen independence and progression to a metastatic phenotype are hallmarks of therapeutic resistance and mortality in breast cancer patients. Metastasis has been associated with chemokine signaling through the SDF-1-CXCR4 axis. Thus, the development of estrogen independence and endocrine therapy resistance in breas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-3185

    authors: Rhodes LV,Short SP,Neel NF,Salvo VA,Zhu Y,Elliott S,Wei Y,Yu D,Sun M,Muir SE,Fonseca JP,Bratton MR,Segar C,Tilghman SL,Sobolik-Delmaire T,Horton LW,Zaja-Milatovic S,Collins-Burow BM,Wadsworth S,Beckman BS,Wood CE

    更新日期:2011-01-15 00:00:00

  • Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.

    abstract::Twenty-eight patients with metastatic malignant melanoma received anti-p97 murine monoclonal antibody (96.5) infused over 2 h at doses between 1 and 20 mg coupled to either 2.5 or 5.0 mCi of 111In by the bifunctional chelating agent diethyltriaminepentaacetic acid. Clearance of 111In from plasma closely fit an open, o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosenblum MG,Murray JL,Haynie TP,Glenn HJ,Jahns MF,Benjamin RS,Frincke JM,Carlo DJ,Hersh EM

    更新日期:1985-05-01 00:00:00

  • Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2.

    abstract::Neurofibromatosis type 2 (NF2) is a dominantly inherited cancer disorder caused by mutations at the NF2 gene locus. Merlin, the protein product of the NF2 gene, has been shown to negatively regulate Rac1 signaling by inhibiting its downstream effector kinases, the p21-activated kinases (Pak). Given the implication of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0866

    authors: Yi C,Wilker EW,Yaffe MB,Stemmer-Rachamimov A,Kissil JL

    更新日期:2008-10-01 00:00:00

  • Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole.

    abstract::Approximately 25% of breast cancers do not express the estrogen receptor-α (ERα) and consequently do not respond to endocrine therapy. In these tumors, ERα repression is often due to epigenetic modifications such as methylation and histone deacetylation. For this reason, we investigated the ability of the histone deac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2458

    authors: Sabnis GJ,Goloubeva O,Chumsri S,Nguyen N,Sukumar S,Brodie AM

    更新日期:2011-03-01 00:00:00

  • Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction.

    abstract::The expression of cytochrome P450 genes directly within target cells is an important determinant of human susceptibility to cancers, birth defects, and other chemically initiated diseases. One pivotal gene, CYP1A1, codes for an inducible cytochrome P450 isozyme (P450IA1) responsible for the bioactivation of numerous c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Omiecinski CJ,Redlich CA,Costa P

    更新日期:1990-07-15 00:00:00

  • Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors.

    abstract::O6-Alkylguanine, a DNA adduct formed by nitrosoureas, becomes the site of a point mutation during DNA synthesis by preferentially base mispairing with thymine rather than correctly base pairing with cytosine. To repair this adduct, cells contain a limited amount of O6-alkylguanine-DNA alkyltransferase (alkyltransferas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gerson SL,Trey JE,Miller K,Benjamin E

    更新日期:1987-01-01 00:00:00

  • Identification of an inactivating cysteine switch in protein kinase Cepsilon, a rational target for the design of protein kinase Cepsilon-inhibitory cancer therapeutics.

    abstract::Critical roles played by some protein kinases in neoplastic transformation and progression provide a rationale for developing selective, small-molecule kinase inhibitors as antineoplastic drugs. Protein kinase Cepsilon (PKCepsilon) is a rational target for cancer therapy, because it is oncogenic and prometastatic in t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1989

    authors: Chu F,Koomen JM,Kobayashi R,O'Brian CA

    更新日期:2005-11-15 00:00:00

  • The effects of bleomycin on immunocompetence in man.

    abstract::Bleomycin was administered to six patients with advanced cancer. Multiple parameters of both antibody- and cell-mediated immunity were followed serially to characterize the effects of bleomycin on immunocompetence in humans. Antibody-mediated immunity, including primary vaccination with keyhole limpet hemocyanin, was ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lehane DE,Hurd E,Lane M

    更新日期:1975-10-01 00:00:00

  • Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

    abstract::Transduction of mitogenic signals in cells can be mediated by molecules derived from the synthesis and breakdown of the major membrane phospholipid, phosphotidylcholine. Studies were performed on human mammary epithelial cells in culture to understand the impact of malignant transformation and progression on membrane ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Aboagye EO,Bhujwalla ZM

    更新日期:1999-01-01 00:00:00

  • Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction.

    abstract::Our laboratory has found genomic imprinting of a large genomic domain of human 11p15.5, identifying six imprinted genes within this domain: (a) insulin-like growth factor II (IGF-II), an important autocrine growth factor in a wide variety of malignancies; (b) H19, an untranslated RNA that is a putative growth suppress...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Feinberg AP

    更新日期:1999-04-01 00:00:00

  • β-catenin contributes to lung tumor development induced by EGFR mutations.

    abstract::The discovery of somatic mutations in EGFR and development of EGFR tyrosine kinase inhibitors (TKI) have revolutionized treatment for lung cancer. However, resistance to TKIs emerges in almost all patients and currently no effective treatment is available. Here, we show that β-catenin is essential for development of E...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0184

    authors: Nakayama S,Sng N,Carretero J,Welner R,Hayashi Y,Yamamoto M,Tan AJ,Yamaguchi N,Yasuda H,Li D,Soejima K,Soo RA,Costa DB,Wong KK,Kobayashi SS

    更新日期:2014-10-15 00:00:00

  • Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells.

    abstract::A translationally regulated, dominant-negative isoform of CCAAT/enhancer-binding protein beta is expressed in transplantable and primary mouse mammary tumors of different etiologies but is not expressed in preneoplastic mammary hyperplasias or in primary prostate, lung, lens, ovary or lymphoid tumors. The eukaryotic i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Raught B,Gingras AC,James A,Medina D,Sonenberg N,Rosen JM

    更新日期:1996-10-01 00:00:00

  • Induction of lymphoma in antigenically stimulated athymic mice.

    abstract::Athymic mice infected with pinworms or carrying human tumor xenografts frequently develop a lymphoproliferative disorder which eventually leads to lymphoma. By immunofluorescent analysis of involved tissues, the lymphomas appear to be mixtures of null cells, B-cells, and T-cells. When each lymphoma is established in t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Baird SM,Beattie GM,Lannom RA,Lipsick JS,Jensen FC,Kaplan NO

    更新日期:1982-01-01 00:00:00

  • Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma.

    abstract::Because efficient i.v. administration of interleukin 2 (IL-2) in tumor patients leads to severe cardiopulmonary side effects, we developed a new form of IL-2 application that allows activation of all IL-2-responsive immune cells directly at the tumor site. In five patients with T4N0M0 transitional cell carcinoma of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huland E,Huland H

    更新日期:1989-10-01 00:00:00

  • Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.

    abstract::Hepsulfam (NSC 329680, 1,7-heptanediol disulfamate) is an alkylating agent that showed excellent activity against mouse and human mammary carcinoma in preclinical studies. We therefore studied the cytotoxicity of this drug in six human breast cancer cell lines (AdrRMCF7, WTMCF7, Hs578T, MDA-MB-231, T47D, and MDA-MB-46...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Armstrong DK,Gordon GB,Hilton J,Streeper RT,Colvin OM,Davidson NE

    更新日期:1992-03-15 00:00:00

  • Expression of endogenously activated secreted or cell surface carboxypeptidase A sensitizes tumor cells to methotrexate-alpha-peptide prodrugs.

    abstract::Methotrexate (MTX) is one of the most commonly used agents in the treatment of solid malignancies; however, the toxicities of MTX to bone marrow and gastrointestinal tract complicate this therapy. We, therefore, propose a gene-dependent enzyme prodrug therapy to limit these toxicities by localizing the production of M...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hamstra DA,Pagé M,Maybaum J,Rehemtulla A

    更新日期:2000-02-01 00:00:00

  • Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice.

    abstract::Tumor endothelial marker 8 (TEM8) is a recently described protein that is preferentially expressed within tumor endothelium. We have developed a fusion protein that targets TEM8 and disrupts tumor vasculature by promoting localized thrombosis. Fusion protein specificity and function were evaluated using Western blot a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0725

    authors: Fernando S,Fletcher BS

    更新日期:2009-06-15 00:00:00

  • Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

    abstract::Prostate-specific membrane antigen (PSMA), initially defined by monoclonal antibody (mAb) 7E11, is a now well-characterized type 2 integral membrane glycoprotein expressed in a highly restricted manner by prostate epithelial cells. 7E11 has been shown to bind an intracellular epitope of PSMA that, in viable cells, is ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Liu H,Moy P,Kim S,Xia Y,Rajasekaran A,Navarro V,Knudsen B,Bander NH

    更新日期:1997-09-01 00:00:00

  • The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.

    abstract::p51/p63 is a novel p53 homologue that has been shown to act as a transcriptional activator through the p53-binding sequence of the p21/WAF1 promoter and to induce apoptosis when it is expressed transiently in a human tumor cell line. We developed transcription assay systems for these two related genes in both Saccharo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shimada A,Kato S,Enjo K,Osada M,Ikawa Y,Kohno K,Obinata M,Kanamaru R,Ikawa S,Ishioka C

    更新日期:1999-06-15 00:00:00

  • EBV is necessary for proliferation of dually infected primary effusion lymphoma cells.

    abstract::Epstein Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are found together in approximately 80% of primary effusion lymphomas (PEL), but their contribution to these cancers is unclear. We found that dominant-negative derivatives of EBNA1 inhibited EBV-positive PEL cells from forming colonies. Those...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0627

    authors: Mack AA,Sugden B

    更新日期:2008-09-01 00:00:00